Topiramate in frontal lobe epilepsy

Acta Neurologica Scandinavica

Volumn 115, Issue 2, 2007, Pages 132-135

  Verrotti, A ^a,g   Sofia, V ^b   Franzoni, E ^c   Coppola, G ^d   Manco, R ^a   Ciambra, G L ^e   Savasta, S ^f   Chiarelli, F ^a   Iannetti, P ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g Policlinico Universitario   (Italy)

Author keywords

Antiepileptic drugs; Frontal lobe epilepsy; Monotherapy; Topiramate

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ARTICLE; BLOOD DISEASE; CHILD; CONTROLLED STUDY; CONVALESCENCE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRONTAL LOBE EPILEPSY; HUMAN; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NERVOUSNESS; NEWBORN; SEIZURE THRESHOLD; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY, FRONTAL LOBE; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845911199     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00758.x     Document Type: Article

References (13)

1. SINCLAIR DB, WHEATLEY M, SNYDER T. Nocturnal frontal lobe epilepsy in childhood. Pediatr Neurol 2003;30:169-76.
2. DI CORCIA G, BLASETTI A, DE SIMONE M, VERROTTI A, CHIARELLI F. Recent advances an autosomal dominant nocturnal frontal lobe epilepsy: 'understanding the nicotinic acetylcholine receptor (nAChR)'. Eur J Pediatr Neurol 2005;9:59-66.
3. PROVINI F, PLAZZI G, LUGARESI E. From nocturnal paroxysmal distonia to nocturnal frontal lobe epilepsy. Clin Neurophysiol 2000;111(Suppl. 2):2-8.
4. PROVINI F, PLAZZI G, TINUPER P et al. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 1999;122:1017-31.
5. SHANK R, GARDOCKI JF, STREETER AJ, MARYANO BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action. Epilepsia 2000;41(Suppl. 1):S66-71.
6. REIFE R, PLEDGER G, WU SC. Topiramate as add-on therapy: pooled analysis of randomised controlled trials in adults. Epilepsia 2000;41(Suppl. 1):566-71.
7. OLDANI A, MANCONI M, ZUCCONI M, FERINI-STRAMBI L. The treatment of nocturnal frontal lobe epilepsy with topiramate. Neurol Sci 2005;26(Suppl.):S214.
8. GROSSO S, FRANZONI E, COPPOLA G et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 2005;14:248-53.
9. BEN-MENACHEM E, HENRIKSEN O, DAM M et al. Doubleblind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
10. COPPOLA G, CALIENDO G, VEGGIOTTI P et al. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastant syndrome: an Italian multicentric study. Epilepsy Res 2002;51:147-53.
11. GILMAN JT, DUCHOWNY M. Childhood epilepsy - current therapeutic recommendations. CNS Drugs 1994;1:180-92.
12. ROSENFELD WE, DENNIS RD, SALLY AW, BALDASSARRE JS, ROSS AR. A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatr Neurol 1999;20:339-44.
13. STEFAN LJ, SILLS GJ, BRODIE MJ. Topiramate in refractory epilepsy: a prospective observational study. Epilepsia 2000;41:977-80.